lifestyle.capitolhilltimes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Business
Latest Business News
FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month
WIRE NEWS NETWORK
February 17, 2026
Erdene Expands Mineralization at Zuun Mod Molybedenum-Copper Project
Erdene Resource Development Corporation
February 17, 2026
Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
Chemomab Therapeutics Ltd.
February 17, 2026
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Cingulate Inc.
February 17, 2026
Refinity Validates Breakthrough Waste Conversion Technology, Advancing Toward Commercial Demonstration
Innventure, Inc.
February 17, 2026
Holzer & Holzer, LLC Reminds RR Investors of the April 3, 2026 Lead Plaintiff Deadline in the Richtech Robotics Inc. Securities Class Action
Holzer & Holzer
February 17, 2026
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026
Phathom Pharmaceuticals
February 17, 2026
Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases
Cue Biopharma, Inc.
February 17, 2026
AI Loves Data – The Natural Evolution of Data Science Salon
Data Science Salon
February 17, 2026
Checkmarx Enhances IDE-Native Agentic Application Security in Kiro
Checkmarx
February 17, 2026
Prev
1
…
7,816
7,817
7,818
7,819
7,820
…
30,387
Next
Channels
Follow Us
X
LinkedIn